CVS Health Corporation with ticker code (CVS) now have 24 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $91.12 and $59.00 and has a mean share price target at $67.39. (at the time of writing). Now with the previous closing price of $56.12 this is indicating there is a potential upside of 20.1%. The day 50 moving average is $59.84 while the 200 day moving average is $64.79. The market capitalization for the company is 71.43B. The stock price is currently at: $56.49 USD
The potential market cap would be $85,772,410,376 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 10.05, revenue per share of $284.37 and a 2.87% return on assets.
CVS Health Corporation, together with its subsidiaries, is a diversified health solutions company. The Company’s segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Its Health Care Benefits offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and diagnostic testing.
